Advanced search
Start date
Betweenand

Clinical and laboratory findings associated with IL - 17 in systemic lupus erythematosus

Grant number: 10/13636-2
Support Opportunities:Scholarships in Brazil - Master
Effective date (Start): March 01, 2011
Effective date (End): February 28, 2013
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal Investigator:Simone Appenzeller
Grantee:Karina de Oliveira Peliçari
Host Institution: Faculdade de Ciências Médicas (FCM). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
Associated research grant:08/02917-0 - Blood and cerebrospinal fluid biomarkers associated with structural and functional central nervous system abnormalities in systemic lupus erythematosus, AP.JP

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown origin partially characterized by periods of activity and remission. The highest incidences are in female patients of working age, but can involve young patients (JSLE), which are patients who have diagnostic closed until 16 years of age. Nonspecific manifestations such as weight loss, fever, fatigue, hair loss and arthralgias are frequently observed in patients with SLE, but are not very specific, occurring also in other systemic diseases. In more specific manifestations of SLE can be found mainly arthritis, renal, skin and others. Through the examination of blood from patients with SLE is possible to measure markers of antibodies, proteins and inflammation that may increase according to disease activity. T cells play an important role in protection against extracellular pathogens, but Th17 cells specific for self antigens are highly pathogenic. Among the other cytokines, the cells Th17 produce IL - 17 which has been implicated in many chronic autoimmune diseases. However, if IL-17 plays a role in the pathogenesis of systemic lupus erythematosus (SLE) remains unclear. The objective is to dose levels of IL17 in patients with adult and juvenile SLE, first-degree relatives and healthy controls matched for age and IL17 levels correlate with clinical, laboratory, disease activity and cumulative damage (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
POSTAL, MARIANA; SINICATO, NAILU ANGELICA; PELICARI, KARINA OLIVEIRA; MARINI, ROBERTO; LAVRAS COSTALLAT, LILIAN TEREZA; APPENZELLER, SIMONE. Clinical and serological manifestations associated with interferon-alpha levels in childhood-onset systemic lupus erythematosus. Clinics, v. 67, n. 2, p. 157-162, . (10/13636-2, 09/11076-2, 09/06049-6, 08/02917-0, 10/13637-9)
PELICARI, KARINA DE OLIVEIRA; POSTAL, MARIANA; SINICATO, NAILU ANGELICA; PERES, FERNANDO AUGUSTO; FERNANDES, PAULA TEIXEIRA; MARINI, ROBERTO; LAVRAS COSTALLAT, LILIAN TEREZA; APPENZELLER, SIMONE. Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus. Clinics, v. 70, n. 5, p. 313-317, . (08/02917-0, 12/21071-0, 10/13636-2)
MARIANA POSTAL; NAILU ANGÉLICA SINICATO; KARINA OLIVEIRA PELIÇARI; ROBERTO MARINI; LILIAN TEREZA LAVRAS COSTALLAT; SIMONE APPENZELLER. Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus. Clinics, v. 67, n. 2, p. 157-162, . (09/11076-2, 10/13636-2, 08/02917-0, 09/06049-6, 10/13637-9)
Academic Publications
(References retrieved automatically from State of São Paulo Research Institutions)
PELIÇARI, Karina de Oliveira. Clinical and laboratory manifestations associated to IL-17 in childhood-onset systemic lupus erythematosus. 2013. Master's Dissertation - Universidade Estadual de Campinas (UNICAMP). Faculdade de Ciências Médicas Campinas, SP.

Please report errors in scientific publications list by writing to: gei-bv@fapesp.br.